Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Emergent Biosolutions Inc. (EBS)  
$2.59 0.15 (6.15%) as of 4:30 Wed 3/27


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 53,590,000
Market Cap: 138.80(M)
Last Volume: 1,065,495 Avg Vol: 1,074,222
52 Week Range: $1.5 - $13.21
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NYSE COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  507
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Emergent BioSolutions is a life sciences company focused on providing a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). Co. is focused on products and solutions that address the following five distinct PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives; emerging infectious diseases; travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). Co. has a product portfolio of ten marketed products (vaccines, therapeutics, and drug-device combination products).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 3,530 8,611
Total Sell Value $0 $0 $29,527 $160,247
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 2 5
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 720
  Page 1 of 29  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hartzel William SVP, Bioservices   •       –      –    2024-03-05 4 D $3.41 $1,180 D/D (346) 34,939     -
   Lindahl Richard S EVP, Chief Financial Officer   •       –      –    2024-03-01 4 D $3.39 $2,319 D/D (684) 158,742     -
   Glessner Coleen EVP, Quality & Ethics, and CPL   •       –      –    2024-03-01 4 D $3.39 $1,292 D/D (381) 164,968     -
   Williams Paul Anthony SVP, Products Business   •       –      –    2024-03-01 4 D $3.39 $464 D/D (137) 24,882     -
   Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec   •       –      –    2024-03-01 4 D $3.39 $2,383 D/D (703) 173,758     -
   Lindahl Richard S EVP, Chief Financial Officer   •       –      –    2024-02-29 4 D $3.23 $29,190 D/D (9,037) 159,426     -
   Williams Paul Anthony SVP, Products Business   •       –      –    2024-02-29 4 D $3.23 $1,454 D/D (450) 25,019     -
   Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec   •       –      –    2024-02-29 4 D $3.23 $13,253 D/D (4,103) 174,461     -
   Lindahl Richard S EVP, Chief Financial Officer   •       –      –    2024-02-23 4 D $2.74 $1,417 D/D (517) 168,463     -
   Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec   •       –      –    2024-02-23 4 D $2.74 $627 D/D (229) 178,564     -
   Williams Paul Anthony SVP, Products Business   •       –      –    2024-02-23 4 D $2.74 $288 D/D (105) 25,469     -
   Lindahl Richard S EVP, Chief Financial Officer   •       –      –    2024-02-21 4 D $2.71 $10,873 D/D (4,012) 168,980     -
   Williams Paul Anthony SVP, Products Business   •       –      –    2023-11-13 4 D $1.82 $1,030 D/D (566) 25,574     -
   Hartzel William SVP, Bioservices   •       –      –    2023-11-11 4 D $2.00 $1,264 D/D (632) 35,285     -
   Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec   •       –      –    2023-11-11 4 D $2.00 $826 D/D (413) 178,793     -
   Fowler Neal Franklin Director   –       •      –    2023-10-03 4 A $0.00 $0 D/D 118,670 118,670     -
   Degolyer Donald W Director   –       •      –    2023-10-03 4 A $0.00 $0 D/D 118,670 118,670     -
   Hartzel William SVP, BioservicesOfficer   •       –      –    2023-08-08 3 IO $0.00 $0 D/D 0 35,917 -65%     
   Williams Paul Anthony SVP, Products Business   •       –      –    2023-07-08 4 D $0.00 $0 D/D (85) 26,140     -
   Lindahl Richard S EVP, Chief Financial Officer   •       –      –    2023-06-09 4 A $0.00 $0 D/D 73,847 172,992     -
   Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec   •       –      –    2023-06-09 4 A $0.00 $0 D/D 73,847 179,206     -
   Kramer Robert President and CEO   •       •      –    2023-06-09 4 A $0.00 $0 D/D 212,308 506,059     -
   Glessner Coleen EVP, Quality & Ethics, and CPL   •       –      –    2023-06-09 4 A $0.00 $0 D/D 46,155 165,349     -
   Havey Adam EVP, Business Operations   •       –      –    2023-06-09 4 A $0.00 $0 D/D 73,847 174,398     -
   Williams Paul Anthony SVP, Products Business   •       –      –    2023-06-09 4 A $0.00 $0 D/D 13,847 26,225     -

  720 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 29
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed